Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He, Zi Hui, Li Xu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113946-113946
Closed Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
S. Rajaraman, Ranjani Balakrishnan, Dhruv Deshmukh, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 885-908
Closed Access | Times Cited: 6
Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR)
Liwei Wang, Songwei Jiang, Yinghui Yuan, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2491-2491
Open Access | Times Cited: 9
Discovery of selective HDAC6 inhibitors based on a multi-layer virtual screening strategy
Xingang Liu, Wenying Yan, Songsong Wang, et al.
Computers in Biology and Medicine (2023) Vol. 160, pp. 107036-107036
Closed Access | Times Cited: 5
HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance
Emma Robinson, Rushita A. Bagchi, Jennifer L. Major, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 19
Open Access | Times Cited: 5
Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities
Nguyen Quang Khai, Tran Khac Vu
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 18-29
Closed Access | Times Cited: 5
Rational design of metabolically stable HDAC inhibitors: An overhaul of trifluoromethyl ketones
Riddhidev Banerjee, Endri Karaj, Sabitri Lamichhane, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114807-114807
Open Access | Times Cited: 8
Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia
Kehui Zhang, Rui Huang, Ming Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116015-116015
Closed Access | Times Cited: 4
Machine Learning Approaches to Predict the Selectivity of Compounds against HDAC1 and HDAC6
Berna Doğan
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 06, pp. 837-850
Closed Access | Times Cited: 1
Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry
Nian‐Dong Mao, Yueying Xu, Xia Yao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107973-107973
Closed Access | Times Cited: 1
Epigenetic regulation of cancer stem cells: Shedding light on the refractory/relapsed cancers
Libo Xu, Jinghua Zhang, Jicheng Sun, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115110-115110
Closed Access | Times Cited: 7
Reading and erasing of histone crotonyllysine mimics by the AF9 YEATS domain and SIRT2 deacylase
Nurgül Bilgin, Vildan A. Türkmen, Nesrin Hammami, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117500-117500
Open Access | Times Cited: 3
Discovery and SAR analysis of 5-chloro-4-((substituted phenyl)amino)pyrimidine bearing histone deacetylase inhibitors
Lin Zhang, Yiming Chen, Fahui Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1918-1927
Open Access | Times Cited: 5
Discovery of Indole-Piperazine Hybrid Structures as Potent Selective Class I Histone Deacetylases Inhibitors
Liang Xing, Guoliang Gong, Xinyang Chen, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 71, Iss. 3, pp. 206-212
Open Access | Times Cited: 2
Establishing And Maintaining The Blood-Brain Barrier: Epigenetic And Signaling Determinants
Jayanarayanan Sadanandan, Sithara Thomas, Iny Elizabeth Mathew, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 2
Exploring Derivatives of Quinolizidine Alkaloid Sophoridine in the Design and Biological Mechanistic Evaluation of Histone Deacetylase Inhibitors against Triple‐Negative Breast Cancer
Linlin Dai, Cheng Tan, Hui Wang, et al.
ChemMedChem (2023) Vol. 19, Iss. 2
Closed Access | Times Cited: 2
Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids
Virginija Jakubkienė, Gabrielius Ernis Valiulis, Markus Schweipert, et al.
Beilstein Journal of Organic Chemistry (2022) Vol. 18, pp. 837-844
Open Access | Times Cited: 3
Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
Jie Wang, Chi Zhou, Bo Li, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 4, pp. 687-702
Closed Access
Design, Synthesis, and Biological Evaluation of Novel Aak1/Hdacs Dual Inhibitors Against Sars-Cov-2 Entry
Xiang‐Yang Ye, Nian‐Dong Mao, Yueying Xu, et al.
(2024)
Closed Access
Synthesis and histone deacetylases inhibitory activity of pyrimidine‐based 1,3,4‐oxadiazoles
Virginija Jakubkienė, I. Labalaukyte, Markus Schweipert, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 9, pp. 1426-1438
Closed Access
Discovering novel derivatives of STAT3 and HDAC inhibitors with anti‐tumor activity
Yuchao Yang, Yamin Pu, Xiaoli Huang, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 1
Closed Access
HDAC8 as a target in drug discovery: function, structure and design
Qianlong Zhao, Hongyan Liu, Jie Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116972-116972
Closed Access
Establishing And Maintaining The Blood-Brain Barrier: Epigenetic And Signaling Determinants
Jayanarayanan Sadanandan, Sithara Thomas, Iny Elizabeth Mathew, et al.
(2024)
Open Access
Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier
Jayanarayanan Sadanandan, Sithara Thomas, Iny Elizabeth Mathew, et al.
eLife (2024) Vol. 12
Open Access
Overview of drugs approved by the FDA in 2022
Д. В. Куркин, Е. И. Морковин, Д. А. Бакулин, et al.
Pharmacy & Pharmacology (2023) Vol. 11, Iss. 3, pp. 193-210
Open Access | Times Cited: 1
Machine learning approaches to quantitively predict selectivity of compounds against hDAC1 and hDAC6 isoforms
Berna Doğan
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Scroll to top